Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
Stenotrophomonas maltophilia is one of the most common emerging multi-drug resistant organisms found in the lungs of people with cystic...
Claire’s Place Foundation Launches COVID-19 Emergency Fund for People with Cystic Fibrosis
Claire’s Place Foundation medical expert recommends all with cystic fibrosis self-quarantine immediately Claire’s Place Foundation, a...
COVID-19: NGO Commends Nana Addo For Suspending Foreign Travels For Gov’t Officials
The Management and Board of Community Focus Foundation Ghana (CFF-GH) has applauded the President of Ghana, H.E Nana Addo Dankwa...
New CRISPR Tool Fixes CFTR Mutations in CF Patients’ Stem Cells, Study Finds
A new variation of the gene-editing technology CRISPR-Cas9 can correct mutations in the CFTR gene — the genetic cause of cystic fibrosis...
New drugs aim to disarm the immune system’s ‘atomic bomb’ cells
Seeking a new treatment for people who have dangerous blockages in their coronary arteries, doctors in London are trying to disarm the...
Inhaled Messenger RNA Treatment Fast-Tracked for Cystic Fibrosis
The Food and Drug Administration has granted Fast Track designation to MRT5005 (Translate Bio), an inhaled messenger RNA (mRNA)...
COVID-19 in Chronic Lung Disease: What You Need to Know
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and novel coronavirus disease (COVID-19) have been of major concern to the...
This new treatment helps 90% of cystic fibrosis patients breathe better
Vertex’s Trikafta was the second-fastest FDA approval in history, and could help some 27,000 patients. In October 2019, Vertex...
CFTR Amplifiers May Be Potent CF Mono or Combo Therapy, Study Says
Amplifiers, a potential new class of therapies that modify CFTR — the protein whose defects cause cystic fibrosis (CF) — do so by...
UK NICE to Announce Decision on Vertex’s Therapy Trikafta in December
The National Institute for Health and Care Excellence (NICE) in the U.K. is currently in the process of evaluating Vertex...
